NAFLD prevalence in older patients with T2DM

被引：0
|
作者：
Kotsiliti, Eleni
机构：
[1] Nature Reviews Gastroenterology & Hepatology,
来源：
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2023年 / 20卷 / 02期
关键词：
D O I：
10.1038/s41575-022-00733-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [1] NAFLD prevalence in older patients with T2DM
    Eleni Kotsiliti
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 65 - 65
  • [2] Insulin Secretion and Sensitivity Pattern Is Different in patients With T2DM Only or Patients With T2DM and NAFLD
    Pan, Xiaoyu
    Liu, Qing
    Song, Kexiu
    Chai, Shangyu
    Li, Fei
    Huang, Yueye
    Bhavna, Bhavna
    Jhummon, Navina Priya
    Qu, Shen
    DIABETES, 2013, 62 : A492 - A492
  • [3] A prospective cohort study for the prevalence and screening policy of NAFLD in patients with T2DM in primary care
    Forlano, Roberta
    Mullish, Benjamin H.
    Yee, Michael
    Goldin, Robert D.
    Thursz, Mark
    Manousou, Pinelopi
    JOURNAL OF HEPATOLOGY, 2021, 75 : S558 - S559
  • [4] PREVALENCE OF UNDIAGNOSED NAFLD/ NASH IN T2DM AS DETERMINED BY TE AND LAB TESTS
    Pockros, Paul J.
    Prevallet, Alexander
    Khanna, Rohit
    Van Uem, Stephanie
    Puglisi, Leah
    Tsimikas-Phyllis, Athena
    HEPATOLOGY, 2022, 76 : S612 - S613
  • [5] Are Plasma Aminotransferases of Value in Screening Patients with T2DM for NAFLD or Fibrosis?
    Rocha, Andrea Ortiz
    Leiva, Eddison Godinez
    Kalavalapalli, Srilaxmi
    Lomonaco, Romina
    Shetty, Shwetha S.
    Marangi, Stephen A.
    Saenz, Enrique Valdez
    Shrestha, Sulav
    Gonzalez, Maria A.
    Chi, Xiaofei
    Gurka, Matthew J.
    Barb, Diana
    Cusi, Kenneth
    DIABETES, 2023, 72
  • [6] Prevalence of NAFLD/NASH in a Predominantly Hispanic Population and Role of Insulin Resistance and T2DM
    Cusi, Kenneth
    Ortiz-Lopez, Carolina
    Orsak, Beverly
    Finch, Joan
    Lomonaco, Romina M.
    DIABETES, 2010, 59 : A411 - A411
  • [7] Gut microbial metabolites in obesity, NAFLD and T2DM
    Emanuel E. Canfora
    Ruth C. R. Meex
    Koen Venema
    Ellen E. Blaak
    Nature Reviews Endocrinology, 2019, 15 : 261 - 273
  • [8] Gut microbial metabolites in obesity, NAFLD and T2DM
    Canfora, Emanuel E.
    Meex, Ruth C. R.
    Venema, Koen
    Blaak, Ellen E.
    NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (05) : 261 - 273
  • [9] NAFLD with selective T2DM: An independent clinical entity?
    Qu, Shen
    Liu, Qing
    Li, Wenjun
    Chen, Shengguan
    Han, Yuqi
    Wang, Jiying
    Yang, Peng
    Cheng, Xiaoyun
    ENDOCRINE JOURNAL, 2010, 57 : S347 - S347
  • [10] Dapagliflozin Is Safe and Well Tolerated in Older Patients with T2DM
    Mansfield, Traci
    Fioretto, Paola
    Ptaszynska, Agata
    Yavin, Yshai
    Apanovitch, Anne Marie
    Johnsson, Eva
    Parikh, Shamik J.
    List, James F.
    DIABETES, 2014, 63 : A71 - A71
12345